Blueprint Medicines Corporation (BPMC) Social Stream
BLUEPRINT MEDICINES CORP (BPMC) Price Targets From Analysts
Use the tables below to see what analysts covering BLUEPRINT MEDICINES CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 9 | $136 | $84 | $113.222 | $54.28 | 108.59% |
| 2021-11-10 | 9 | $136 | $84 | $114.444 | $54.28 | 110.84% |
| 2021-11-19 | 9 | $136 | $84 | $115.777 | $54.28 | 113.3% |
| 2021-11-29 | 9 | $136 | $84 | $115.555 | $54.28 | 112.89% |
| 2022-01-12 | 9 | $135 | $84 | $113.333 | $54.28 | 108.79% |
| 2022-01-25 | 9 | $135 | $84 | $110.555 | $54.28 | 103.68% |
| 2022-01-31 | 9 | $135 | $84 | $108.444 | $54.28 | 99.79% |
| 2022-02-08 | 9 | $135 | $84 | $104.777 | $54.28 | 93.03% |
| 2022-02-17 | 9 | $133 | $82 | $100.625 | $54.28 | 85.38% |
| 2022-03-01 | 10 | $133 | $71 | $97.333 | $54.28 | 79.32% |
| 2022-04-12 | 10 | $133 | $71 | $97.888 | $54.28 | 80.34% |
| 2022-04-28 | 10 | $133 | $68 | $97.555 | $54.28 | 79.73% |
| 2022-05-04 | 10 | $133 | $68 | $96.7 | $54.28 | 78.15% |
| 2022-05-18 | 10 | $152 | $65 | $100.272 | $54.28 | 84.73% |
| 2022-06-01 | 10 | $152 | $65 | $99.363 | $54.28 | 83.06% |
| 2022-06-10 | 10 | $152 | $41 | $96.909 | $54.28 | 78.54% |
| 2022-06-14 | 10 | $152 | $41 | $92.454 | $54.28 | 70.33% |
| 2022-07-27 | 12 | $152 | $40 | $86.461 | $54.28 | 59.29% |
| 2022-08-02 | 10 | $152 | $40 | $86.461 | $54.28 | 59.29% |
| 2022-08-03 | 13 | $152 | $40 | $89.642 | $54.28 | 65.15% |
| 2022-08-17 | 13 | $152 | $40 | $88.214 | $54.28 | 62.52% |
| 2022-08-18 | 13 | $152 | $40 | $87.285 | $54.28 | 60.81% |
| 2022-08-22 | 13 | $152 | $40 | $87.714 | $54.28 | 61.6% |
| 2022-09-06 | 13 | $152 | $40 | $88.428 | $54.28 | 62.91% |
| 2022-10-10 | 14 | $152 | $40 | $89.533 | $54.28 | 64.95% |
| 2022-10-26 | 14 | $152 | $40 | $89.8 | $54.28 | 65.44% |
| 2022-11-02 | 15 | $152 | $40 | $85.133 | $54.28 | 56.84% |
| 2022-11-04 | 16 | $115 | $40 | $78.733 | $54.28 | 45.05% |
| 2022-12-12 | 16 | $115 | $40 | $78.4 | $54.28 | 44.44% |
| 2022-12-14 | 17 | $115 | $40 | $77.25 | $54.28 | 42.32% |
| 2022-12-20 | 17 | $115 | $40 | $77.437 | $54.28 | 42.66% |
| 2023-01-23 | 17 | $115 | $41 | $77.5 | $54.28 | 42.78% |
| 2023-02-06 | 17 | $115 | $41 | $75.375 | $54.28 | 38.86% |
| 2023-02-10 | 17 | $115 | $41 | $75.062 | $54.28 | 38.29% |
| 2023-02-14 | 17 | $115 | $41 | $74.625 | $54.28 | 37.48% |
| 2023-02-17 | 17 | $115 | $41 | $72.125 | $54.28 | 32.88% |
| 2023-02-23 | 17 | $114 | $41 | $69.875 | $54.28 | 28.73% |
| 2023-02-27 | 17 | $114 | $38 | $69.25 | $54.28 | 27.58% |
| 2023-02-28 | 17 | $114 | $38 | $69.25 | $54.28 | 27.58% |
| 2023-03-28 | 17 | $114 | $38 | $69.5 | $54.28 | 28.04% |
| 2023-04-25 | 17 | $114 | $38 | $69.5 | $54.28 | 28.04% |
| 2023-05-05 | 17 | $114 | $41 | $70.2 | $54.28 | 29.33% |
| 2023-05-23 | 18 | $114 | $41 | $72.437 | $54.28 | 33.45% |
The Trend in the Analyst Price Target
Over the past 36 months, BPMC's average price target has gone down $18.51.
BPMC reports an average of 57.67% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-18 | 13 | 152 | 40 | 87.285 | 64.09 | 36.19% |
| 2022-12-14 | 17 | 115 | 40 | 77.250 | 46.73 | 65.31% |
| 2023-01-23 | 17 | 115 | 41 | 76.937 | 46.51 | 65.42% |
| 2023-02-28 | 17 | 114 | 38 | 69.250 | 42.37 | 63.44% |
| 2023-03-28 | 17 | 114 | 38 | 69.500 | 42.57 | 63.26% |
BPMC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.94 | 10 | 1 | 6 | 1 | 1 | 18 |
The Trend in the Broker Recommendations
BPMC's average broker recommendation rating improved by 0.26 over the prior 26 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- BPMC has a lower variance in analysts' estimates than -3942.19% of all US stocks.
- In the context of stocks in the mid market cap category, BLUEPRINT MEDICINES CORP's number of analysts covering the stock is greater than 4275.24% of them.
- BLUEPRINT MEDICINES CORP's average analyst price target is higher than 4150.48% of Pharmaceutical Products stocks.
- BLUEPRINT MEDICINES CORP's upside potential (average analyst target price relative to current price) is higher than 1582.78% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, MCRB, ASND, and QURE are the three stocks most similar to BLUEPRINT MEDICINES CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BPMC a Buy, Hold or Sell? See the POWR Ratings now!